Funny how quinlash downplays the complete loss of $225 million of investors money - it's no big deal.
Does that sound like someone concerned about his fellow investors - or someone paid to promote Tilray.
As far as $800 million revenue - any clown who has access to investors money can acquire additional companies to increase revenue.
What a competent manager does - is show a concern with gross margin, efficient cost control and bottom line net profit - or in Tilrays case, a $3 billion usd net loss since 2021.
The fact remains that quinlash and his 'research' - wasn't aware that Tilray carries Medmen on their books. THAT island his other continual uninformed mis infornation and misleading pists is all you need to know about your good 'friend' quinlash
Comment by
quinlashon Aug 15, 2024 12:34pm 
37 Views
Post# 36180836
RE:TLRY / Medmen was back in 2021
The amount remaining on the books for Medmen is peanuts in comparison to annual net revenues of almost 800 million USD.
The armada of new product releases being put forward by the company will be upping revenue numbers further on future reports. Upcoming report is expected to be cash positive for all operations.
Get distracted by the little stuff and you miss the big picture.
Your money, your trade / investment.